Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Details Narrative)

v3.23.1
Stockholders’ Equity (Details Narrative) - USD ($)
 3 Months Ended
Mar. 07, 2023
Mar. 28, 2022
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Nov. 30, 2022
Class of Stock [Line Items]            
Designated preferred stock, shares     20,000,000   20,000,000  
Preferred stock, per share     $ 0.001   $ 0.001  
Preferred stock, stated value     $ 13,625,000    
Common stock, shares issued     41,753,603   40,518,792  
Common stock, shares outstanding     41,753,603   40,518,792  
Proceeds from issuance of common stock     $ 284,000    
Common Stock, Value, Issued     $ 42,000   $ 41,000  
Commited Equity Facility [Member]            
Class of Stock [Line Items]            
Sale of Stock, Percentage of Ownership after Transaction     4.00%      
Controlled Equity Offering Agreement [Member]            
Class of Stock [Line Items]            
Sale of Stock, Percentage of Ownership after Transaction     3.00%      
Common Stock, Value, Issued           $ 6,500,000
Sale of Stock, Number of Shares Issued in Transaction     230,068      
Sale of Stock, Consideration Received Per Transaction     $ 300,000      
Cantor Fitzgerald [Member] | Commited Equity Facility [Member]            
Class of Stock [Line Items]            
Sale of Stock, Consideration Received on Transaction   $ 50,000,000        
Issuance of common stock   680,263        
Proceeds from issuance of common stock   $ 1,800,000        
Lucid Diagnostics Inc [Member]            
Class of Stock [Line Items]            
Majority-interest equity ownership shares     31,302,420      
Series A Preferred Stock [Member]            
Class of Stock [Line Items]            
Designated preferred stock, shares 13,625          
Preferred stock, per share $ 0.001          
Share price, per share $ 1,000          
Proceeds from convertible preferred stock $ 13,625,000          
Preferred stock, stated value $ 1,000          
Preferred stock, conversion price per share $ 1.394          
Preferred stock dividend payment terms The holders of Series A Preferred Stock will be entitled to dividends payable as follows: (i) a number of shares of Common Stock equal to 20% of the number of shares of Common Stock issuable upon conversion of the Series A Preferred Stock then held by such Holder on March 7, 2024, and (ii) a number of shares of Common Stock equal to 20% of the number of shares of Common Stock issuable upon conversion of the Series A Preferred Stock then held by such Holder on March 7, 2025. A holder that converts its Series A Preferred Stock prior to March 7, 2024 or March 7, 2025, as the case may be, will not receive the dividend that accrues on such date with respect to such converted Series A Preferred Stock. The holders of the Series A Preferred Stock also will be entitled to dividends equal, on an as-if-converted to shares of Common Stock basis, to and in the same form as dividends actually paid on shares of the Common Stock when, as, and if such dividends are paid on shares of the Common Stock          
Conversion of stock, description The Company will not effect any conversion of the Series A Preferred Stock, and a holder will not have the right to receive dividends or convert any portion of the Series A Preferred Stock, to the extent that, after giving effect to the receipt of dividends or the conversion, the holder (together with such holder’s affiliates, and any persons acting as a group together with such holder or any of the holder’s affiliates) would beneficially own in excess of 4.99% of the Company’s outstanding common stock (or, upon election of the holder, 9.99% of the Company’s outstanding common stock)